JPRN-UMIN000004036已完成1 期
Rehabilitation for secondary lymphedema of lower limbs Lymphatic transportation measurement with ICG lymphography and the effect of rehabilitation - Rehabilitation and ICG lymphography for secondary lymphedema of lower limbs
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1.phlegmonitis 2.leakage of lymphatic fluid 3.deep venous thrombosis and sever aneurysm 4.poor general status(Performance Status 3 or more) 5.acute generalized inflammation and fever(38.0 centidegree or more) 6.severe heart failure 7.pulmonary embolism, acute respiratory failure, severe pulmonary hypertension 8.severe hepatic and renal failure 9.severe mental disorder, sever psychological diseases 10.other metabolic disorders (acute thyroiditis etc.)
研究者
相似试验
已完成
不适用
Therapeutic effect of upper limb lymphedema after radical operation of mastocarcinoma with Wen Tong Xiao Zhong Wai Fu Fangh for external wet coverpper limb lymphedema after radical operation of mastocarcinomaOther postprocedural disorders of circulatory system, not elsewhere classifiedCancerISRCTN43361464Beijing Municipal Science and Technology Commission (China)96
Unknown
3 期
Prophylactic LYMphatic Reconstruction (LYMbR) to Prevent Lymphedema After Node Dissection for Cutaneous MalignanciesLymphedema of LimbMalignant Skin NeoplasmNCT05136079Alberta Health Services, Calgary40
已完成
1 期
Preventive surgery to improve postoperative lymphedema in lower limb after total hysterectomy by lymphatic venous anastomosis procedure utilizing da Vinci Surgical System (Phase I study)Endometrial cancerJPRN-UMIN000030133CHIBA TOKUSHUKAI HOSPITA3
尚未招募
不适用
Examination of the lymphedema improvement with the surgical combination therapy for secondary limbs lymphedemaymphedemaJPRN-UMIN000022689Cancer Institute Hospital50
已完成
2 期
Clinical Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema (AdeLE)Secondary LymphedemaNCT03658967Herantis Pharma Plc.39